A Relative Bioavailability Study of Alprazolam 3 mg Extended Release Tablets Under Non-fasting Conditions

NCT00865657 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Alprazolam 3 mg Extended Release Tablets, single dose
DRUG: XANAX XR® 3 mg tablets, single dose

Sponsor

Actavis Inc.